News
-
-
PRESS RELEASE
AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients
AB Science announces new publication on medRxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in amyotrophic lateral sclerosis patients -
-
-
-
-
-
-
-
PRESS RELEASE
Commerzbank Rejects UniCredit’s Hostile Approach; Reaffirms Superior Value of Standalone Momentum Strategy
Commerzbank rejects UniCredit's hostile approach, reaffirms standalone strategy value, highlighting lack of premium offer and absence of concrete combination plan. Strategic update on 8 May 2026